Two cases of serious food-borne infection in patients treated with anti-TNF-α. Are we doing enough to reduce the risk? [7]

Rheumatology

Volumn 45, Issue 2, 2006, Pages 237-238

  Makkuni, D ^a   Kent, R ^a   Watts, R ^a   Clunie, G ^a  

^a IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Accessibility of health care; Musculoskeletal diseases; Self referral

Indexed keywords

AMOXICILLIN; CIPROFLOXACIN; INDOMETACIN; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

AGED; ANKYLOSING SPONDYLITIS; ARTHROSCOPY; BACTERIAL INFECTION; BACTERIUM CULTURE; CASE REPORT; CHEESE; DIARRHEA; DISEASE ASSOCIATION; DISEASE TRANSMISSION; FECES ANALYSIS; FEMALE; FEVER; FOOD CONTAMINATION; FOOD SAFETY; HUMAN; INFECTION RISK; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; LETTER; LISTERIA MONOCYTOGENES; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK REDUCTION; SALMONELLA; SYNOVIAL FLUID;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; FOOD POISONING; HUMANS; MALE; OPPORTUNISTIC INFECTIONS; SALMONELLA FOOD POISONING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 31544483972     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei123     Document Type: Letter

References (10)

1. Centres for Disease Control and Prevention. Multistate outbreak of listeriosis - United States 2000. Morbidity and Mortality Weekly. JAMA 2001;285:285-6.
2. Listeria monocytogenes infections in England and Wales. CDR Weekly 2004;14:37.
3. Slifman NR, Greshon SK, Lee J-H, Edwards ET, Braun MM. Listeria monocytogenes infection as a complication of treatment with tumour necrosis α neutralisisng agents. Arthritis Rheum 2003;48:319-24.
4. Pagliano P, Attanasio V, Fusco U, Mohamed DA, Rossi M, Faella FS. Does etanercept monotherapy enhance the risk of Listeria monocytogenes meningitis? Ann Rheum Dis 2004; 63:462-3.
5. Bowie VL, Snella KA, Gopalachar AS, Bharadwaj P. Listeria meningitis associated with infliximab. Ann Pharmacother 2004;38: 58-61.
6. Dixon W, Hyrich K, Watson K, Silman A, Symmons D and The BSR Biologics Register. Serious infection rates in patients receiving biologic therapy in the United Kingdom. Rheumatology 2005;44(Suppl. 1):i11.
7. Katsarolis I, Tsiodras S, Panagopoulous P et al. Septic arthritis due to Salmonella enteritidis associated with infliximab use. Scand J Infect Dis 2005;37:304-6.
8. Natea MG, Radstake T, Joosten LA, van der Meer JW, Barrera P, Kullberg BJ. Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumour necrosis therapy: Association with decreased interferon-gamma production and Toll-like receptor 4 expression. Arthritis Rheum 2003;48:1853-7.
9. Salmonella infections in England and Wales. CDR Weekly 2004; 15:14.
10. Pinner RW, Schuchat A, Swaminathan B et al. Role of foods in sporadic listeriosis. II. Microbiologic and epidemiologic investigation. The Listeria Study Group. JAMA 1992;267:2081-2.